Gallentes, Shairamae D.
HRN: 21-71-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
CEFUROXIME 500MG (TAB)
08/24/2022
08/31/2022
ORAL
500mg
Q12
Thick MSAF; UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes